期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Successful Treatment of Life-Threatening Cerebral Bleeding Associated with Disseminated Intravascular Coagulation Using Recombinant Human Soluble Thrombomodulin in a Patient with Mixed Phenotype Acute Leukemia with t (9;22) (q34;q11.2);<i>Bcr-Abl1</i>
1
作者 Naoki Takezako Takashi Ishii +3 位作者 Akihisa Nagata Naohiro Sekiguchi Satoshi Noto Akiyoshi Miwa 《International Journal of Clinical Medicine》 2013年第1期52-57,共6页
Recently, mixed phenotype acute leukemia (MPAL) with t (9;22) (q34;q11.2);bcr-abl1 was described as one kind of acute leukemia of ambiguous lineage in the 2008 World Health Organization Classification of Tumors of Hem... Recently, mixed phenotype acute leukemia (MPAL) with t (9;22) (q34;q11.2);bcr-abl1 was described as one kind of acute leukemia of ambiguous lineage in the 2008 World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues. However, treatment strategy remains difficult for this uncommon MPAL. In addition, this type of MPAL is at high risk of tumor lysis syndrome (TLS) because of high chemo-sensitivity. Here, we report a MPAL with t (9;22) (q34;q11.2);bcr-abl1 case that suffered from life-threatening cerebral bleeding associated with disseminated intravascular coagulation (DIC) with TLS after bcr-abl positive acute lymphoblastic leukemia (ALL) type induction therapy who was successfully treated with recombinant human thrombomodulin (rhTM). This case reached complete remission without additive cerebral bleeding. In conclusion, bcr-abl positive ALL type induction therapy was effective for MPAL with t (9;22) (q34;q11.2);bcr-abl1 and rhTM was effective against DIC with TLS. 展开更多
关键词 MIXED PHENOTYPE Acute Leukemia with t (9 22) (q34 q11.2) Bcr-Abl1 RECOMBINANT Human Soluble Thrombomodulin Imatinib Disseminated Intravascular Coagulation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部